Literature DB >> 27213557

Murine Prostate Micro-dissection and Surgical Castration.

Kenneth C Valkenburg1, Sarah R Amend2, Kenneth J Pienta2.   

Abstract

Mouse models are used extensively to study prostate cancer and other diseases. The mouse is an excellent model with which to study the prostate and has been used as a surrogate for discoveries in human prostate development and disease. Prostate micro-dissection allows consistent study of lobe-specific prostate anatomy, histology, and cellular characteristics in the absence of contamination of other tissues. Testosterone affects prostate development and disease. Androgen deprivation therapy is a common treatment for prostate cancer patients, but many prostate tumors become castration-resistant. Surgical castration of mouse models allows for the study of castration resistance and other facets of hormonal biology on the prostate. This procedure can be coupled with testosterone reintroduction, or hormonal regeneration of the prostate, a powerful method to study stem cell lineages in the prostate. Together, prostate micro-dissection and surgical castration opens up a multitude of opportunities for robust and consistent research of prostate development and disease. This manuscript describes the protocols for prostate micro-dissection and surgical castration in the laboratory mouse.

Entities:  

Mesh:

Year:  2016        PMID: 27213557      PMCID: PMC4942087          DOI: 10.3791/53984

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

Review 1.  The role of estrogens in normal and abnormal development of the prostate gland.

Authors:  Gail S Prins; Liwei Huang; Lynn Birch; Yongbing Pu
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

Review 2.  Pathology of benign prostatic hyperplasia.

Authors:  C G Roehrborn
Journal:  Int J Impot Res       Date:  2008-12       Impact factor: 2.896

3.  5α-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy.

Authors:  Laura E Pascal; Khalid Z Masoodi; Katherine J O'Malley; Daniel Shevrin; Jeffrey R Gingrich; Rahul A Parikh; Zhou Wang
Journal:  J Urol       Date:  2014-10-31       Impact factor: 7.450

4.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

Review 5.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

Review 6.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

7.  Of mice and men--warning: intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively.

Authors:  J P Michiel Sedelaar; Susan S Dalrymple; John T Isaacs
Journal:  Prostate       Date:  2013-06-15       Impact factor: 4.104

Review 8.  Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Authors:  Scott B Shappell; George V Thomas; Richard L Roberts; Ron Herbert; Michael M Ittmann; Mark A Rubin; Peter A Humphrey; John P Sundberg; Nora Rozengurt; Roberto Barrios; Jerrold M Ward; Robert D Cardiff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

9.  Isolation, cultivation and characterization of adult murine prostate stem cells.

Authors:  Rita U Lukacs; Andrew S Goldstein; Devon A Lawson; Donghui Cheng; Owen N Witte
Journal:  Nat Protoc       Date:  2010-03-25       Impact factor: 13.491

10.  A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Authors:  Xi Wang; Marianna Kruithof-de Julio; Kyriakos D Economides; David Walker; Hailong Yu; M Vivienne Halili; Ya-Ping Hu; Sandy M Price; Cory Abate-Shen; Michael M Shen
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

View more
  6 in total

1.  Testosterone strongly enhances azoxymethane/dextran sulfate sodium-induced colorectal cancer development in C57BL/6 mice.

Authors:  Chin-Hee Song; Nayoung Kim; Ryoung Hee Nam; Soo In Choi; Jeong Eun Yu; Heewon Nho; Eun Shin; Ha-Na Lee; Young-Joon Surh
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

2.  Characterization of tumor-associated macrophages in prostate cancer transgenic mouse models.

Authors:  Amber E de Groot; Kayla V Myers; Timothy E G Krueger; Ashley L Kiemen; Natalia H Nagy; Alexandria Brame; Vicente E Torres; Zhongyuan Zhang; Levent Trabzonlu; W Nathaniel Brennen; Denis Wirtz; Angelo M De Marzo; Sarah R Amend; Kenneth J Pienta
Journal:  Prostate       Date:  2021-05-05       Impact factor: 4.012

3.  A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer.

Authors:  Jonathan F Anker; Hanlin Mok; Anum F Naseem; Praveen Thumbikat; Sarki A Abdulkadir
Journal:  J Vis Exp       Date:  2018-03-06       Impact factor: 1.355

4.  Development and Characterization of a Sin Nombre Virus Transmission Model in Peromyscus maniculatus.

Authors:  Bryce M Warner; Derek R Stein; Bryan D Griffin; Kevin Tierney; Anders Leung; Angela Sloan; Darwyn Kobasa; Guillaume Poliquin; Gary P Kobinger; David Safronetz
Journal:  Viruses       Date:  2019-02-21       Impact factor: 5.048

5.  Sympathetic signaling facilitates progression of neuroendocrine prostate cancer.

Authors:  Shubham Dwivedi; Maricris Bautista; Sanskriti Shrestha; Hussain Elhasasna; Tanaya Chaphekar; Frederick S Vizeacoumar; Anand Krishnan
Journal:  Cell Death Discov       Date:  2021-11-22

6.  Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.

Authors:  Morgan T Walcheck; Kristina A Matkowskyj; Anne Turco; Simon Blaine-Sauer; Manabu Nukaya; Jessica Noel; Oline K Ronnekleiv; Sean M Ronnekleiv-Kelly
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.